Single-dose Safety Study of APD916 in Healthy Volunteers

Status:
Completed

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

The APD916-001 study is designed primarily to evaluate the safety and tolerability of APD916 when administered as a single dose

Phase 1

Arena Pharmaceuticals